191 related articles for article (PubMed ID: 23448385)
1. Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity.
AlFadhli S
Genet Test Mol Biomarkers; 2013 Apr; 17(4):336-41. PubMed ID: 23448385
[TBL] [Abstract][Full Text] [Related]
2. Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population.
Kimkong I; Nakkuntod J; Sae-Ngow S; Snabboon T; Avihingsanon Y; Hirankarn N
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):229-35. PubMed ID: 22053592
[TBL] [Abstract][Full Text] [Related]
3. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
[TBL] [Abstract][Full Text] [Related]
4. Association of Hashimoto's thyroiditis with cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and inducible co-stimulator (ICOS) genes in a Kuwaiti population.
Alfadhli S; Almutawa Q; Abbas JM; Doi SA
Endocrine; 2013 Jun; 43(3):666-77. PubMed ID: 23138463
[TBL] [Abstract][Full Text] [Related]
5. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
Louthrenoo W; Kasitanon N; Wongthanee A; Kuwata S; Takeuchi F
Int J Rheum Dis; 2021 Nov; 24(11):1378-1385. PubMed ID: 34533895
[TBL] [Abstract][Full Text] [Related]
6. Association of CTLA-4 (+49 A/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis.
Yu L; Shao M; Zhou T; Xie H; Wang F; Kong J; Xu S; Shuai Z; Pan F
Int Immunopharmacol; 2021 Jul; 96():107617. PubMed ID: 33866246
[TBL] [Abstract][Full Text] [Related]
7. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
[TBL] [Abstract][Full Text] [Related]
8. Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism.
Patel H; Mansuri MS; Singh M; Begum R; Shastri M; Misra A
PLoS One; 2016; 11(3):e0149441. PubMed ID: 26963610
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus.
Dahal LN; Basu N; Youssef H; Khanolkar RC; Barker RN; Erwig LP; Ward FJ
Arthritis Res Ther; 2016 Aug; 18():180. PubMed ID: 27487771
[TBL] [Abstract][Full Text] [Related]
10. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method.
Matsushita M; Tsuchiya N; Shiota M; Komata T; Matsuta K; Zama K; Oka T; Juji T; Yamane A; Tokunaga K
Tissue Antigens; 1999 Dec; 54(6):578-84. PubMed ID: 10674972
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
12. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.
Chang WW; Zhang L; Yao YS; Su H
Mol Biol Rep; 2012 Sep; 39(9):9159-65. PubMed ID: 22718509
[TBL] [Abstract][Full Text] [Related]
13. Association of interferon regulatory factor 5 (IRF5) markers with an increased risk of lupus and overlapping autoimmunity in a Kuwaiti population.
AlFadhli S; Jahabani I
Ann Hum Biol; 2014; 41(6):531-9. PubMed ID: 24697591
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus.
Liu MF; Wang CR; Chen PC; Fung LL
Scand J Immunol; 2003 Jun; 57(6):568-72. PubMed ID: 12791095
[TBL] [Abstract][Full Text] [Related]
15. Association between 318C/T polymorphism of the CTLA-4 gene and systemic lupus erythematosus in Iranian patients.
Shojaa M; Aghaie M; Amoli M; Javid N; Shakeri F; Khashayar P; Tabarraei A; Keshtkar AA; Joshaghani HR; Kouroshnia A; Qorbani M; Mahmoudi F; Mohebbi R; Ranjbarpour N
Int J Rheum Dis; 2017 Dec; 20(12):2040-2044. PubMed ID: 24400885
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis.
Wang K; Zhu Q; Lu Y; Lu H; Zhang F; Wang X; Fan Y
Genet Test Mol Biomarkers; 2017 Apr; 21(4):222-227. PubMed ID: 28384040
[TBL] [Abstract][Full Text] [Related]
17. Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; Contribution markers of inflammation and oxidative stress.
Tanhapour M; Vaisi-Raygani A; Bahrehmand F; Khazaei M; Kiani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):56-61. PubMed ID: 27894401
[TBL] [Abstract][Full Text] [Related]
18. Association of CTLA4 exon-1 polymorphism with the tumor necrosis factor-α in the risk of systemic lupus erythematosus among South Indians.
Katkam SK; Kumaraswami K; Rupasree Y; Thishya K; Rajasekhar L; Kutala VK
Hum Immunol; 2016 Feb; 77(2):158-64. PubMed ID: 26582004
[TBL] [Abstract][Full Text] [Related]
19. Influence of endothelial nitric oxide synthase gene intron-4 27bp repeat polymorphism on its expression in autoimmune diseases.
AlFadhli S
Dis Markers; 2013; 34(5):349-56. PubMed ID: 23481632
[TBL] [Abstract][Full Text] [Related]
20. Influence of HumDN1 VNTR polymorphism on DNASE1 expression in systemic lupus erythematosus and rheumatoid arthritis.
AlFadhli S; Ghanem AA
Immunol Invest; 2014; 43(5):411-23. PubMed ID: 24564745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
